Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2019 year
    12
    12 day
    Signing ceremony for strategic cooperation between Winhealth Pharma and Resources Guangdong Pharma

    On November 27, 2019, Hongkong Winhealth Pharma Group Co., Ltd and China Resources Guangdong Pharmaceutical Co., Ltd. reached a strategic cooperation in Guangzhou, and reached a long-term and comprehensive strategic partnership on the China Resources distribution of Compound Heparin Sodium Allantoin Gel (produced by Merz Pharma GmbH & Co.KGaA) and Tauroursodeoxycholic Acid Capsule (produced by Doppel FarmEUTICI S. R. L).


    Ms. Chen Yanli, deputy general manager, Mr. Wu Chuanzhou, sales director, and Mr. Guan Zixuan, purchasing manager of China Resources Guangdong Pharmaceutical Co., Ltd., Mr. Chen Huiming, commercial operation director, Mr. Chen Jingyu, business manager of Nanda District, Mr. Li Yanghao, regional business manager of Hongkong Winhealth Pharma Group Co., Ltd, as well as representatives and leaders of both parties attended the signing ceremony. 

      

    强强联合,携手共赢丨香港维健医药集团与华润广东医药有限公司达成战略合作协议 强强联合,携手共赢丨香港维健医药集团与华润广东医药有限公司达成战略合作协议


    Director Chen Huiming gave an introduction to the unique CDCO (Contract Development and Commercialization Organization) model, the Company's introduction of new products and business expansion in the new retail sector. 

    Ms. Chen Yanli, deputy general manager of China Resources Guangdong Pharmaceutical Co., Ltd., also gave an introduction to the efforts made by China Resources Guangdong Pharmaceutical Co., Ltd. in optimizing the construction of commercial distribution channels and retail distribution channels. 


    This cooperation is another important strategic achievement of Hongkong Winhealth Pharma Group Co., Ltd after the 2.0 upgrade and transformation. Under the unique CDCO (Contract Development and Commercialization Organization) model, we will uphold the corporate values of 'cooperation, dedication, challenge and development' and carry out more and deeper cooperation. Let's work hand in hand to win together.


    强强联合,携手共赢丨香港维健医药集团与华润广东医药有限公司达成战略合作协议 强强联合,携手共赢丨香港维健医药集团与华润广东医药有限公司达成战略合作协议


    About Hong Kong Winhealth Pharma Group

    Founded in Hangzhou in 2006 and headquartered in Hong Kong, China, Winhealth Pharma Group is a one-stop professional service platform focusing on the whole process from drug registration submission, product import, market access, commercialization and life cycle management.


    As a new pharmaceutical enterprise promoting the development of China pharmaceuticals and health industry, Winhealth Pharma Group is dedicated to introducing world-leading health products and medical technologies into the China market, providing more excellent therapies and medical information dissemination channels for medical workers and more treatment and rehabilitation resources for patients, and creating a leading full-cycle, integrated and customized market access solution supplier and CDCO (contract development and commercialization organization, a commercialization service platform).


    Please visit the official website of Hong Kong Winhealth Pharma Group for more information: http://www.winhealth.hk/


    About China Resources Guangdong Pharmaceutical Co., Ltd.

    China Resources Guangdong Pharmaceutical Co., Ltd. (hereinafter referred to as 'China Resources Guangdong Pharmaceutical') is a strategic development platform for pharmaceutical circulation set up in Guangdong Province by CR Pharma Comm, a subsidiary of China Resources Holdings. China Resources Guangdong Pharmaceutical has prefecture-level subsidiaries in a number of cities, such as Shantou, Foshan, Zhuhai, Zhongshan, Shenzhen, Dongguan, Huizhou, and Maoming, as well as two specialized subsidiaries, namely Teck Soon Hong and China Resources Guangzhou Medical Devices. They are distributed in the core cities in the Guangdong-Hong Kong-Macao Greater Bay Area, with a total of over 1,000 employees. The business scope covers drug import trade, medical terminal sales, commercial distribution, retail chain, medical equipment and supply-chain-related value-added services. Over the years, the Company's business scale has maintained rapid development, with sales revenue exceeding 20 billion yuan, ranking first in the pharmaceutical circulation industry in Guangdong Province. 


    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.